| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
34,920,000 |
| Market
Cap: |
71.59(M) |
| Last
Volume: |
62,823 |
Avg
Vol: |
29,734 |
| 52
Week Range: |
$1.85 - $3.31 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ INDUSTRIAL |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : 8.3 |
| Insider 6 Months : 13.1 |
| Insider 3/6 Months : 21.6 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Spherix is a biotechnology company seeking to develop small-molecule anti-cancer therapeutics. Co. owns the rights to patented technology from universities and researchers and it is in the process of developing therapeutic drugs through partnerships with educational institutions. Co.'s pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Co.'s AML and ALL compounds are targeted therapeutics designed to overcome various resistance mechanisms observed with the existing standard of care. DHA-dFdC, Co.'s pancreatic drug, is a compound poised to become the chemotherapy treatment for pancreatic cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
44,944 |
147,748 |
215,424 |
506,510 |
| Total Buy Value |
$129,063 |
$342,771 |
$526,695 |
$2,135,564 |
| Total People Bought |
2 |
3 |
3 |
4 |
| Total Buy Transactions |
4 |
17 |
42 |
68 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Yu Soo |
Director |
– • • |
2024-04-08 |
4 |
B |
$2.99 |
$25,390 |
I/I |
8,500 |
13,750 |
2.25 |
-25% |
|
| Hayes Anthony |
CEO |
• • – |
2024-04-05 |
4 |
B |
$2.88 |
$38,823 |
I/I |
13,500 |
116,248 |
2.66 |
-33% |
|
| Hayes Anthony |
CEO |
• • – |
2024-04-04 |
4 |
B |
$2.62 |
$10,339 |
I/I |
3,944 |
102,748 |
2.58 |
-25% |
|
| Yu Soo |
Director |
– • • |
2024-04-04 |
4 |
B |
$2.84 |
$54,511 |
I/I |
19,000 |
9,500 |
2.25 |
-25% |
|
| Devall Christopher Franklin |
COO |
• – – |
2023-12-26 |
4 |
B |
$2.55 |
$17,863 |
D/D |
7,000 |
30,033 |
2.74 |
-14% |
|
| Yu Soo |
Director |
– • • |
2023-12-26 |
4 |
B |
$2.60 |
$12,997 |
I/I |
5,000 |
9,000 |
2.17 |
-14% |
|
| Yu Soo |
Director |
– • • |
2023-12-21 |
4 |
A |
$2.02 |
$1,272,701 |
D/D |
630,050 |
1,448,908 |
|
- |
|
| Hayes Anthony |
CEO |
• • – |
2023-12-20 |
4 |
B |
$2.00 |
$140,168 |
I/I |
70,000 |
98,804 |
2.66 |
10% |
|
| Yu Soo |
Director |
– • • |
2023-12-12 |
4 |
B |
$2.02 |
$8,122 |
I/I |
4,000 |
4,000 |
2.17 |
41% |
|
| Hayes Anthony |
CEO |
• • – |
2023-12-12 |
4 |
B |
$2.00 |
$8,012 |
I/I |
4,000 |
28,804 |
2.58 |
41% |
|
| Devall Christopher Franklin |
COO |
• – – |
2023-11-30 |
4 |
B |
$2.28 |
$2,278 |
D/D |
1,000 |
23,033 |
2.66 |
28% |
|
| Devall Christopher Franklin |
COO |
• – – |
2023-11-28 |
4 |
B |
$2.26 |
$2,259 |
D/D |
1,000 |
22,033 |
2.66 |
33% |
|
| Yu Soo |
Director |
– • • |
2023-11-27 |
4 |
B |
$2.20 |
$2,200 |
I/I |
1,000 |
24,000 |
2.17 |
30% |
|
| Hayes Anthony |
CEO |
• • – |
2023-11-24 |
4 |
B |
$2.16 |
$3,200 |
I/I |
1,481 |
24,804 |
2.58 |
41% |
|
| Hayes Anthony |
CEO |
• • – |
2023-11-22 |
4 |
B |
$2.09 |
$2,765 |
I/I |
1,323 |
23,323 |
2.58 |
36% |
|
| Yu Soo |
Director |
– • – |
2023-11-20 |
4 |
B |
$2.05 |
$4,103 |
I/I |
2,000 |
23,000 |
2.1 |
22% |
|
| Hayes Anthony |
CEO |
• • – |
2023-11-16 |
4 |
B |
$1.97 |
$4,916 |
I/I |
2,500 |
22,000 |
2.58 |
24% |
|
| Hayes Anthony |
CEO |
• • – |
2023-11-14 |
4 |
B |
$1.93 |
$4,825 |
I/I |
2,500 |
19,500 |
2.58 |
22% |
|
| Way George |
Chief Financial Officer |
• – – |
2023-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
96,311 |
96,311 |
|
- |
|
| Yu Soo |
Director |
– • – |
2023-09-20 |
4 |
B |
$2.50 |
$39,271 |
I/I |
15,000 |
21,000 |
2.1 |
-8% |
|
| Hayes Anthony |
CEO |
• • – |
2023-09-20 |
4 |
B |
$2.50 |
$38,899 |
I/I |
15,000 |
17,000 |
2.66 |
-8% |
|
| Yu Soo |
Director |
– • – |
2023-09-19 |
4 |
B |
$2.55 |
$5,091 |
I/I |
2,000 |
6,000 |
2.1 |
-7% |
|
| Yu Soo |
Director |
– • – |
2023-09-14 |
4 |
B |
$2.74 |
$5,471 |
I/I |
2,000 |
4,000 |
2.1 |
-24% |
|
| Hayes Anthony |
CEO |
• • – |
2023-09-13 |
4 |
B |
$2.75 |
$5,494 |
I/I |
2,000 |
2,000 |
2.58 |
-20% |
|
| Yu Soo |
Director |
– • – |
2023-09-11 |
4 |
B |
$2.82 |
$5,631 |
I/I |
2,000 |
2,000 |
2.1 |
-20% |
|
105 Records found
|
|
Page 1 of 5 |
|
|
0.07 (3.22%) 
